Gao et al. [10] reported that CCL5 interacts with its unique receptor CCR5 in the tumour microenvironment, which affects the metabolic activity of breast cancer cells, thereby promoting cell tumorigenesis and progression during breast cancer onset. This evidence concerns the gene CCR5 and breast carcinoma.